Tulavi Nerve Therapeutics

Mountain View, United States Founded: 2020 • Age: 6 yrs
Therapeutic devices for neurally mediated diseases are developed.

About Tulavi Nerve Therapeutics

Tulavi Nerve Therapeutics is a company based in Mountain View (United States) founded in 2020.. Tulavi Nerve Therapeutics has raised $4 million across 2 funding rounds. Tulavi Nerve Therapeutics offers products and services including allay™ Nerve Cap. Tulavi Nerve Therapeutics operates in a competitive market with competitors including Avation, BioCircuit, Epineuron, Micro Leads and Renerva, among others.

  • Headquarter Mountain View, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $4 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1 M (USD), Series A

    Dec 16, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Tulavi Nerve Therapeutics

Tulavi Nerve Therapeutics offers a comprehensive portfolio of products and services, including allay™ Nerve Cap. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Hydrogel cap for preventing neuromas and aiding nerve healing in surgery.

Funding Insights of Tulavi Nerve Therapeutics

Tulavi Nerve Therapeutics has successfully raised a total of $4M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $1.0M
  • First Round

    (12 May 2020)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2021 Amount Series A - Tulavi Nerve Therapeutics Valuation

investors

May, 2020 Amount Seed - Tulavi Nerve Therapeutics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Tulavi Nerve Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Tulavi Nerve Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Tulavi Nerve Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Tulavi Nerve Therapeutics

Tulavi Nerve Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avation, BioCircuit, Epineuron, Micro Leads and Renerva, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Wearable tibial nerve stimulation device treats overactive bladder symptoms.
domain founded_year HQ Location
Non-invasive electrophysiology devices are developed to monitor peripheral nerves.
domain founded_year HQ Location
Medical devices for peripheral nerve injury treatment are provided.
domain founded_year HQ Location
Micro-cuff electrodes and wireless pulse generators for neuromodulation are developed.
domain founded_year HQ Location
Implants for peripheral nerve repair are developed for injury treatment.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Tulavi Nerve Therapeutics

Frequently Asked Questions about Tulavi Nerve Therapeutics

When was Tulavi Nerve Therapeutics founded?

Tulavi Nerve Therapeutics was founded in 2020.

Where is Tulavi Nerve Therapeutics located?

Tulavi Nerve Therapeutics is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.

Is Tulavi Nerve Therapeutics a funded company?

Tulavi Nerve Therapeutics is a funded company, having raised a total of $4M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on May 12, 2020.

What does Tulavi Nerve Therapeutics do?

Founded in 2020, Tulavi Nerve Therapeutics is based in Mountain View, United States, within the medical device sector. Therapies targeting nerves to address aberrant neural reflex arcs in peripheral and visceral diseases are developed by the company. These interventions are delivered via surgical and minimally invasive approaches, focusing on neurally mediated conditions. Operations emphasize innovation in neural therapeutics for clinical applications.

Who are the top competitors of Tulavi Nerve Therapeutics?

Tulavi Nerve Therapeutics's top competitors include Avation, Epineuron and RxFunction.

What products or services does Tulavi Nerve Therapeutics offer?

Tulavi Nerve Therapeutics offers allay™ Nerve Cap.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available